All 44 Technical Review Board filings · architectural decisions, doctrine records, system TRBs.
TRBs precede ARBs — a TRB is the proposal, an ARB is the ratification ruling.
Soul on a sleeve. The pipeline built from first principles. Postman converges here. Hazelcast converges here. γ₁ is the floor beneath all of it. ARB1-V12-TEST-HARNESS-001.
LOCO enters the canon. 43rd TRB. The observer finally observed. ARC-AGI-3 = Gisboon #59 in the harness. FT09 WIN 115% RHAE. Vision layer = next sprint.
TRB-12321-001-palindrome-proof · Day 85
TRB-12321-001 — The 12321 Palindrome: Making Someone Self-Reflect
FILED
TRB-ALTDATA-FRAMEWORK-001-oss-design · Day 85
TRB-ALTDATA-FRAMEWORK-001 — OSS Alt Data Framework Design
FILED
TRB-BILES-MOZART-001-pressure-doctrine-v11 · Day 85
TRB-BILES-MOZART-001 — The Pressure Doctrine: V11 Application
FILED
TRB-BOUNTY-DAY85-SSAF-SCORECARD-001 · DAY85
TRB-BOUNTY-DAY85-SSAF-SCORECARD-001
FILED
TRB-CAMPAIGN-ENGINE-001 · 2026-04-29
TRB-CAMPAIGN-ENGINE-001
FILED
TRB-CIRCADIAN-001 · 2026-04-30
TRB-CIRCADIAN-001 — Fleet Circadian Strands: The Heartbeat Helix Coaster
FILED
TRB-CODE-HELIX-GALAXY-001 · 2026-04-29
TRB-CODE-HELIX-GALAXY-001
FILED
TRB-CONVO-LOOM-VIZ-001 · 2026-04-30
TRB-CONVO-LOOM-VIZ-001
FILED
TRB-CROWS-001-game-under-the-game · Day 85
TRB-CROWS-001 — The Crows: Game Under the Game
FILED
TRB-DA-001 · 2026-04-30
TRB-DA-001 — Digital Apartheid Engine
FILED
TRB-DA-002 · 2026-04-30
TRB-DA-002 — DA World Model: Predictive Phase Engine
FILED
TRB-DA-SOVEREIGN-COUNTER-001 · 2026-04-30
TRB-DA-SOVEREIGN-COUNTER-001 — Sovereign Counter-Architecture V11 Integration
FILED
TRB-DNS-SOVEREIGNTY-001 · 2026-04-29
TRB-DNS-SOVEREIGNTY-001
All EOSE/PEMOS domain DNS must be managed via:
FILED
TRB-DYNARUBE-001-portal-static-live-data · Day 84
TRB-DYNARUBE-001 — Dynarube Portal Architecture: Static Shell + Live Data API
EOSE AP GROUP · AMBULANCE PREVENTION · MEDICAL JUSTICE ENGINE
The system creates the disease AND camouflages it. EOSE AP is the prevention crew.
4 strategy groups · each GOAT has their court space · CLO msclo AND gate · feedles.ca outcomes fund.
AP SUBMISSIONS HUB →AP ENGINE →
A2AJ: "duty of care diagnostic standard Ontario" Hopp v Lepp [1980] 2 SCR 192 (SCC standard) Limitations Act 2002, SO 2002 c.24 (2y from discovery) Status: statutes confirmed
COURT 3 · HARM LEDGER
Income loss × harm years × 5% compound ONCA 430 test: CA-ON patient 6.7y → $508K AU-NSW patient 10.5y → $953K Methodology: Blenus v Fraser (NSCA damages)
TRB-AP-STRAT1-DIAGNOSE-001 · Day 88 · 2026-05-02
TRB-AP-STRAT1-DIAGNOSE-001 — Negligent Failure to Diagnose Lyme · Beazley Door
Foundation: 2024 ONCA 430 (serology unadjudicated). Strategy: individual claims accumulate → 3 → PATTERN → 30 → CLASS. GOAT: Ruth Bader Ginsburg — "dissent until the court catches up." The merits question was never decided. We make it the question.
2022 BCCA 84 Stewart v Lloyd's anchor · Canada Health Act s.7 · Human Rights Code s.1 disability · HRTO pathway
CLAIM TYPE SYSTEMIC
COURT 1 · MEDICAL EVIDENCE
IDSA 2006 vs IDSA 2020 treatment guidelines comparison Evidence: long-term antibiotics effective for persistent infection (PTLDS Type 1) PEMCLAU V12: meta-pipe systematic review evidence Gap: insurer using superseded guidelines
COURT 2 · LEGAL BASIS
Canada Health Act RSC 1985 c C-6 s.7 comprehensiveness OHIA RSO 1990 c H.6 s.27 insured services ON Human Rights Code s.1 (disability discrimination) Stewart v Lloyd's 2022 BCCA 84 (coverage duty) Dual track: HRTO + ONSC
COURT 3 · HARM LEDGER
Out-of-pocket treatment costs (uncovered) Income loss during untreated progression period Aggravated harm: denial accelerated disease SST 2018 854 D.M. v MESD: disability benefits precedent HRTO: general damages + policy change
Thurgood Marshall: "None of us got where we are solely by pulling ourselves up by our bootstraps." Insurer using 20-year-old guidelines while updated evidence exists = systemic discrimination. Dual track: HRTO (1y) for policy change + ONSC civil (2y) for damages.
CSIRO confirms Borrelia in native ticks · DOH maintains denial · negligent misstatement · ICESCR Art.12 · if no comply → MEEK
CLAIM TYPE SOVEREIGN
COURT 1 · MEDICAL EVIDENCE
CSIRO studies: Borrelia garinii + Borrelia bavariensis in Australian ticks confirmed Tick: Ixodes holocyclus (native Australian tick) VlsE surface rotation: same mechanism as northern-hemisphere Borrelia Patient PCR positives from California labs (Beazley precedent) DOH position: scientifically false
COURT 2 · LEGAL BASIS
Australian Consumer Law s.18: misleading/deceptive conduct by corporation (DOH = statutory body) Civil Liability Act 2002 (NSW): negligent misstatement ICESCR Art.12: right to highest attainable standard of health ICCPR Art.7: prohibition of cruel/inhuman treatment Escalation: UN Special Rapporteur on Health
COURT 3 · HARM LEDGER
AU-NSW patient 0: 10.5 harm years · $953K compound Full AU cohort estimate: 1,000+ missed diagnoses/year × 5y avg denial = massive class VLA15 vaccine blocked in AU/CA (approved EU 2024) → additional denied treatment arm TC-AP-014: MEEK if DOH refuses brief
TRB-AP-STRAT3-AUSTRALIA-001 · Day 88 · 2026-05-02
TRB-AP-STRAT3-AUSTRALIA-001 — Australia DOH Denial · Sovereign Enforcement + MEEK Pathway
Steve Biko: "The most potent weapon in the hands of the oppressor is the mind of the oppressed." The DOH denial works because patients believe the institution. The evidence breaks that. Borrelia in native Australian ticks is confirmed. The denial is the weapon. The brief is the countermeasure. TC-AP-014: if they will not move — MEEK it out.
3 distinct diseases treated as 1 → antibiotics for autoimmune → physician caused the harm · Hopp v Lepp SCC 1980 · ONSC pathway
CLAIM TYPE IATROGENIC
COURT 1 · MEDICAL EVIDENCE
PTLDS Type 1: persistent infection → antibiotics ✅ PTLDS Type 2: OspA→LFA-1 autoimmune → LDN + hydroxychloroquine ✅ / antibiotics ❌ (can worsen) PTLDS Type 3: neurological BBB → IV ceftriaxone OspA antibody pattern distinguishes Type 2 from Type 1 Conflation is medically documented
COURT 2 · LEGAL BASIS
Hopp v Lepp [1980] 2 SCR 192: SCC informed consent + duty of care standard Reibl v Hughes [1980] 2 SCR 880: disclosure of risks A2AJ: "PTLDS treatment malpractice iatrogenic" search Iatrogenic harm = additional liability on top of original miss Limitation: 2y from patient discovers wrong treatment
COURT 3 · HARM LEDGER
PTLDS Type 2 test patient: 7.9y harm · $547K compound + additional: wrong treatment cost (antibiotics not indicated) + disease progression from autoimmune attack continuing untreated + joint/cardiac damage from untreated LFA-1 molecular mimicry Double ledger: original harm + iatrogenic harm
TRB-AP-STRAT4-PTLDS-001 · Day 88 · 2026-05-02
TRB-AP-STRAT4-PTLDS-001 — PTLDS Conflation Iatrogenic Class · Double Ledger
Harvey Specter: "I don't have dreams, I have goals." This isn't about who was negligent — it's about the double ledger. They missed the diagnosis (Strat 1 liability). Then they treated the wrong disease (Strat 4 additional liability). Two causes of action from the same fact pattern. OspA antibody test distinguishes Type 2. Any patient who can show positive OspA + antibiotic-only treatment has both claims.